Werbung
Werbung
PCSA
Processa Pharmaceuticals, Inc. Common
3.36
USDGesponsert
-0.10
-2.83%
09. Jan., 15:59 UTC -5
Geschlossen
Nach-Markt
3.31
-0.05
-1.55%
PCSA Ergebnisberichte
Positives Überraschungsverhältnis
PCSA übertreffen die 7 der letzten 20Schätzungen.
35%
Nächster Bericht
Datum des nächsten Berichts
18. März 2026
Estimate for Q4 25 (Revenue/ EPS)
--
/-$1.40
Implizierte Änderung von Q3 25 (Revenue/ EPS)
--
/-20.00%
Implizierte Änderung von Q4 24 (Revenue/ EPS)
--
/-92.43%
Processa Pharmaceuticals, Inc. Common earnings per share and revenue
On 06. Nov. 2025, PCSA reported earnings of -1.75 USD per share (EPS) for Q3 25, beating the estimate of -2.04 USD, resulting in a 14.22% surprise. Revenue reached --, compared to an expected --, with a --% difference. The market reacted with a -3.20% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 4 analysts forecast an EPS of -1.40 USD, with revenue projected to reach -- USD, implying an decrease of -20.00% EPS, and -- of --% in Revenue from the last quarter.
FAQ
What were Processa Pharmaceuticals, Inc. Common's earnings and revenue for the latest quarter Q3 2025?
For Q3 2025, Processa Pharmaceuticals, Inc. Common reported EPS of -$1.75, beating estimates by 14.22%, and revenue of --, -- -- expectations.
How did the market react to Processa Pharmaceuticals, Inc. Common's Q3 2025 earnings?
The stock price moved down -3.2%, changed from $7.90 before the earnings release to $7.64 the day after.
When is Processa Pharmaceuticals, Inc. Common expected to report next?
The next earning report is scheduled for 18. März 2026.
What are the forecasts for Processa Pharmaceuticals, Inc. Common's next earnings report?
Based on 4
analysts, Processa Pharmaceuticals, Inc. Common is expected to report EPS of -$1.40 and revenue of -- for Q4 2025.
Which companies are reporting earnings today?
Scheck FXEmpire's Earnings Calendar for today's list of reporting companies.
Werbung